Parmax Pharma Ltd Peer Comparison
PARMAX · Healthcare · Current price ₹136.4
Peers tracked
11
Parmax Pharma Ltd P/E
-40.7x
Sector
Healthcare
Parmax Pharma Ltd vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,743 | 36.9x | 4,18,674 |
| Divi's Laboratories Limited | ₹9,087 | 85.4x | 2,41,311 |
| Torrent Pharmaceuticals Limited | ₹4,558.7 | 86.9x | 1,73,073 |
| Laurus Labs Limited | ₹2,069 | 95.9x | 1,11,434 |
| Zydus Lifesciences Limited | ₹1,113.9 | 24.3x | 1,11,022 |
| Cipla Limited | ₹1,324.1 | 33.2x | 1,07,528 |
| Dr. Reddy's Laboratories Limited | ₹1,242.5 | 29.9x | 1,03,662 |
| Mankind Pharma Limited | ₹2,253.2 | 44.9x | 93,014 |
| Aurobindo Pharma Limited | ₹1,621.4 | 25.9x | 92,924 |
| Lupin Limited | ₹1,939.2 | 17.1x | 89,343 |
| Parmax Pharma Ltd | — | -40.7x | 51 |
Parmax Pharma Ltd versus its peers
Parmax Pharma Ltd operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of -40.7x may be cheap in one industry and expensive in another.
More on Parmax Pharma Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.